Barclays’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$436K Sell
26,385
-24,525
-48% -$404K ﹤0.01% 3307
2026
Q1
$829K Sell
50,910
-142,864
-74% -$2.24M ﹤0.01% 2862
2025
Q4
$2.88M Sell
193,774
-4,541
-2% -$64.2K ﹤0.01% 2661
2025
Q3
$2.55M Sell
198,315
-75,141
-27% -$1M ﹤0.01% 2702
2025
Q2
$4.15M Buy
273,456
+69,479
+34% +$1.08M ﹤0.01% 2281
2025
Q1
$3.41M Sell
203,977
-45,232
-18% -$833K ﹤0.01% 2223
2024
Q4
$4.7M Sell
249,209
-107,806
-30% -$2.08M ﹤0.01% 2220
2024
Q3
$6.71M Buy
357,015
+285,037
+396% +$5.46M ﹤0.01% 1801
2024
Q2
$1.36M Sell
71,978
-103,820
-59% -$1.77M ﹤0.01% 2405
2024
Q1
$2.86M Sell
175,798
-147,152
-46% -$2.15M ﹤0.01% 2273
2023
Q4
$4.09M Buy
322,950
+225,618
+232% +$2.85M ﹤0.01% 2293
2023
Q3
$1.33M Sell
97,332
-6,688
-6% -$103K ﹤0.01% 2148
2023
Q2
$1.79M Buy
104,020
+5,435
+6% +$84.2K ﹤0.01% 1958
2023
Q1
$1.37M Sell
98,585
-11,533
-10% -$170K ﹤0.01% 2501
2022
Q4
$1.47M Sell
110,118
-3,220
-3% -$41.6K ﹤0.01% 2481
2022
Q3
$1.35M Sell
113,338
-62,060
-35% -$882K ﹤0.01% 2002
2022
Q2
$2.23M Sell
175,398
-109,002
-38% -$1.4M ﹤0.01% 1785
2022
Q1
$3.68M Sell
284,400
-99,295
-26% -$1.31M ﹤0.01% 1417
2021
Q4
$6.08M Buy
383,695
+132,489
+53% +$2.26M ﹤0.01% 1564
2021
Q3
$4.89M Buy
251,206
+103,498
+70% +$2.05M ﹤0.01% 1660
2021
Q2
$3.36M Sell
147,708
-113,565
-43% -$2.36M ﹤0.01% 1837
2021
Q1
$4.8M Buy
261,273
+30,164
+13% +$495K ﹤0.01% 1550
2020
Q4
$3.44M Sell
231,109
-40,697
-15% -$531K ﹤0.01% 1800
2020
Q3
$3.05M Buy
271,806
+42,189
+18% +$415K ﹤0.01% 1752
2020
Q2
$1.82M Sell
229,617
-38,922
-14% -$322K ﹤0.01% 2212
2020
Q1
$2.17M Sell
268,539
-169,102
-39% -$2.01M ﹤0.01% 2207
2019
Q4
$5.5M Buy
437,641
+100,528
+30% +$1.08M ﹤0.01% 1899
2019
Q3
$3.01M Buy
337,113
+11,981
+4% +$105K ﹤0.01% 2384
2019
Q2
$2.78M Buy
325,132
+103,034
+46% +$814K ﹤0.01% 2523
2019
Q1
$1.69M Buy
222,098
+58,404
+36% +$470K ﹤0.01% 2754
2018
Q4
$1.35M Sell
163,694
-119,183
-42% -$1.14M ﹤0.01% 2804
2018
Q3
$2.81M Buy
282,877
+182,716
+182% +$1.89M ﹤0.01% 2487
2018
Q2
$981K Sell
100,161
-32,897
-25% -$323K ﹤0.01% 3320
2018
Q1
$1.24M Buy
133,058
+72,109
+118% +$687K ﹤0.01% 2964
2017
Q4
$580K Buy
60,949
+32,883
+117% +$314K ﹤0.01% 3657
2017
Q3
$291K Sell
28,066
-26,983
-49% -$249K ﹤0.01% 4112
2017
Q2
$455K Buy
55,049
+50,689
+1,163% +$380K ﹤0.01% 3625
2017
Q1
$32K Buy
4,360
+1,621
+59% +$11.8K ﹤0.01% 5577
2016
Q4
$20K Sell
2,739
-1,576
-37% -$11K ﹤0.01% 5622
2016
Q3
$31K Sell
4,315
-1,999
-32% -$12.7K ﹤0.01% 5255
2016
Q2
$37K Sell
6,314
-20,594
-77% -$136K ﹤0.01% 5004
2016
Q1
$159K Buy
26,908
+26,797
+24,141% +$144K ﹤0.01% 4012
2015
Q4
$1K Sell
111
-906
-89% -$5.66K ﹤0.01% 5845
2015
Q3
$5K Sell
1,017
-2,712
-73% -$20.1K ﹤0.01% 6053
2015
Q2
$32K Sell
3,729
-737
-17% -$6.19K ﹤0.01% 5422
2015
Q1
$34K Sell
4,466
-349,551
-99% -$2.61M ﹤0.01% 5548
2014
Q4
$2.67M Sell
354,017
-103,816
-23% -$757K ﹤0.01% 2265
2014
Q3
$2.96M Buy
457,833
+399,083
+679% +$3.08M ﹤0.01% 2303
2014
Q2
$475K Sell
58,750
-9,404
-14% -$72.9K ﹤0.01% 4036
2014
Q1
$440K Sell
68,154
-76,759
-53% -$465K ﹤0.01% 4074
2013
Q4
$862K Buy
144,913
+90,007
+164% +$439K ﹤0.01% 3546
2013
Q3
$237K Sell
54,906
-5,412
-9% -$24.7K ﹤0.01% 4879
2013
Q2
$266K Buy
+60,318
New +$267K ﹤0.01% 4900

Other funds holding SEM

Barclays's SEM Position: Q2 2026 in Review

Barclays reduced its Select Medical (SEM) stake by 48% in Q2 2026, selling an estimated $404K and leaving 26,385 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #3307.

Barclays first reported a position in SEM in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.71M in Q3 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Barclays held 26,385 shares of Select Medical worth $436K as of Q2 2026.
  • Barclays sold 24,525 Select Medical shares in Q2 2026, an estimated $404K.
  • Select Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3307 holding.
  • Barclays first reported a position in Select Medical in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Select Medical position peaked at $6.71M in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.